[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
March 15, 1995

Testing for BRCA1 in Hereditary Breast Cancer-Reply

Author Affiliations

OncorMed, Inc Gaithersburg, Md

JAMA. 1995;273(11):846. doi:10.1001/jama.1995.03520350027020

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


In Reply.  —OncorMed provides service for the early detection and treatment of cancer through molecular genetics. This service is provided through physicians, geneticists, and genetic counselors. We share Dr Vance's concerns that the public be educated as to the risks, benefits, advantages, and current limitations of genetic testing. Our marketing material, which is available to physicians and genetic counselors, reflects this concern.We agree with Vance that commercial companies should not be immune to technical and ethical responsibilities involved in genetic testing. All of the physicians and scientists at OncorMed come from academic backgrounds and retain academic affiliations. We work with physicians, bioethicists, medical geneticists, and patient advocates to assure that our services meet the highest standards of quality and integrity. We regret that Vance interprets our position otherwise or that any of our company information would create a difficulty for her or her associates in what is already a

First Page Preview View Large
First page PDF preview
First page PDF preview